Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: Identifying the defective stage and studying the effect of interleukins on NK activity

Tuberculosis

Volumn 81, Issue 5-6, 2001, Pages 343-352

  Nirmala, R ^a   Narayanan, P R ^a   Mathew, R ^a   Maran, M ^b   Deivanayagam, C N ^b  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b GOVERNMENT GENERAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; MINOR HISTOCOMPATIBILITY ANTIGEN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASSAY; CELL ACTIVITY; CELL COUNT; CELL CULTURE; COMORBIDITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035700017     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2001.0309     Document Type: Article

References (48)

1. Global tuberculosis incidence and mortality during 1990-2000
2. Local production of tumor necrosis factor and IFN-γ in tuberculosis pleuritis
3. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. 1. Defective trigger on NK cells for NKCF production by target cells and partial restoration by IL-2
4. Interleukin 2 enhances the depressed natural killer and cytomegalovirus specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome
5. Role of natural killer cytotoxic factors in the mechanism of target cell killing by natural killer cells
6. Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium
7. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium
8. Mechanism of cytotoxicity by natural killer cells
9. Recombinant interleukin 2 enhanced natural killer cell mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens
10. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes
11. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobaceterium tuberculosis-infected human monocytes
12. 2 intermediates
13. Attempts to characterise the mechanisms involved in mycobacterial growth inhibition by gamma interferon activated bone marrow macrophages
14. Cell mediated immune response
15. Quantitative differences in CD8+ lymphocytes; CD4/CD8 ratio, NK cells, and HLA-DR(+)-activated cells of racially different mal populations
16. Natural killer cells in patients with pulmonary tuberculosis
17. Lymphocyte populations during tuberculosis infection. V beta repertoires
18. Reduced natural killer cell activity in multidrug resistant pulmonary tuberculosis
19. Lymphocyte subset counts during the course of community-acquired pneumonia evolution according to age, human immunodeficiency virus status and etiologic microorganisms
20. Tumor targets stimulate IL-2 activated killer cells to produce interferon-γ and tumor necrosis factor
21. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis
22. Effect of interleukin, IL-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection
23. Reduced natural killer cell activity correlates with active disease in HIV patients with multidrug resistant pulmonary tuberculosis
24. Natural killer cells and adenosine deaminase activity in patients with pulmonary tuberculosis
25. Natural killer cells in middle-aged and elderly tuberculosis patients
26. NK cells in carcinomatous and tuberculosis pleurisy. Phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions
27. Commemorative lecture of receiving Imamura Memorial Prize. NK cell in pulmonary tuberculosis from basic and clinical point of view
28. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex 1. Defective trigger on NK cells for NKCF production by target cells and partial restoration by IL-2
29. Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency
30. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate
31. Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood
32. Natural killer function in flow cytometry. 1. Evaluation of NK lytic activity on K562 cell line
33. Natural killer function in flow cytometry. III. Surface marker determination of K562-conjugated lymphocytes by dual laser flow cytometry
34. Increased uptake of vital dye Hoechst 33342 during S phase in synchronized HeLa S3 cells
35. Flow cytometric measurement of NK cell immunoconjugates by pulse width processing
36. Cytokines and infectious diseases
37. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1
38. Acidic polysaccharide from Panax ginseng, ginsan, inducts Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2
39. Dissection of the lymphokine-acivated-killer phenomenon
40. Immunoelectron microscopic studies on the process of tumor cytolysis mediated by lymphokine activated NK cells
41. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
42. Modulation of host defenses by cytokines: Adjuvants in prevention and treatment of serious infection in immunocompromised hosts
43. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes
44. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells